Trial Details

WITHDRAWN
Basic Information
Clinical ID c1738
Identifier NCT02834754
Trial Title Vedolizumab Post Op Study
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Crohn's Disease
Interventions DRUG: Vedolizumab|DRUG: placebo
Participant Information
Sponsor Marc Schwartz
City Pittsburgh
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2018-12-01
Primary Completion Date 2019-05-01
Completion Date 2019-05-01